Tower Research Capital »

Denali Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $214k 13k 16.51
2025-09-30 $107k 7.4k 14.52
2025-06-30 $191k 14k 13.99
2025-03-31 $44k 3.2k 13.60
2024-12-31 $230k 11k 20.38
2024-09-30 $13k 431 29.13
2024-06-30 $484k 21k 23.22
2024-03-31 $29k 1.4k 20.52
2023-09-30 $35k 1.7k 20.63
2023-06-30 $177k 6.0k 29.51
2023-03-31 $92k 4.0k 22.91
2022-12-31 $68k 1.6k 43.48
2022-09-30 $437k 14k 30.76
2022-06-30 $280k 11k 26.67
2022-03-31 $68k 2.1k 32.47
2021-12-31 $343k 7.3k 46.67
2021-09-30 $273k 5.4k 50.33
2021-06-30 $370k 4.5k 81.63
2021-03-31 $437k 7.7k 57.02
2020-12-31 $338k 4.0k 83.73
2020-09-30 $83k 2.3k 35.99
2020-06-30 $252k 9.6k 26.32
2019-09-30 $32k 2.1k 15.27
2019-06-30 $2.0k 115 17.39
2019-03-31 $19k 828 22.95
2018-12-31 $2.0k 107 18.69
2018-06-30 $56k 3.7k 15.27